Get our newsletter delivered directly to your inbox
I have already subscribed | Do not show this message again
Your email has been successfully registered.
The special process would allow the use of the vaccine without having to go through more prolonged registration procedures.
The Russian Direct Investment Fund (RDIF) has presented to the World Health Organization (WHO) a request to register and pre-approve the Sputnik V COVID-19 vaccine, which was developed by the National Centre for Epidemiological and Microbiological Research.
Russia would become one of the first countries in the world to make such a request to the WHO. The international body must then evaluate its efficacy, safety, and reliability based on clinical trials.
The expedited registration of the vaccine would fall under a special process that could authorize the use of the vaccine in emergency situations, such as the current pandemic hitting countries around the world.
The special process would allow the use of the novel vaccine without having to go through more prolonged registration procedures.